Glucometabolic Perturbations in Type 2 Diabetes Mellitus and Coronavirus Disease 2019: Causes, Consequences, and How to Counter Them Using Novel Antidiabetic Drugs - The CAPISCO International Expert Panel.
Popovic DS, Papanas N, Koufakis T, Kotsa K, Mahmeed WA, Al-Rasadi K, Al-Alawi K, Banach M, Banerjee Y, Ceriello A, Cesur M, Cosentino F, Firenze A, Galia M, Goh SY, Janez A, Kalra S, Kempler P, Kapoor N, Lessan N, Lotufo P, Rizvi AA, Sahebkar A, Santos RD, Stoian AP, Toth PP, Viswanathan V, Rizzo M.
Popovic DS, et al. Among authors: koufakis t.
Exp Clin Endocrinol Diabetes. 2023 May;131(5):260-267. doi: 10.1055/a-2019-1111. Epub 2023 Jan 24.
Exp Clin Endocrinol Diabetes. 2023.
PMID: 36693416
Review.